HighTower Advisors, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$4,849,000
+8.9%
47,574
-2.9%
0.01%0.0%
Q1 2023$4,453,000
+123.4%
48,978
-6.5%
0.01%
+100.0%
Q4 2022$1,993,000
+41.0%
52,395
-6.7%
0.01%
+25.0%
Q3 2022$1,413,000
-17.1%
56,150
+0.2%
0.00%0.0%
Q2 2022$1,705,000
-4.6%
56,015
+2.8%
0.00%0.0%
Q1 2022$1,787,000
+23.6%
54,515
-0.6%
0.00%
+33.3%
Q4 2021$1,446,000
-75.7%
54,823
-7.2%
0.00%
-81.2%
Q3 2021$5,944,000
-39.4%
59,090
-14.7%
0.02%
-42.9%
Q2 2021$9,802,000
+66.8%
69,260
+17.5%
0.03%
+47.4%
Q1 2021$5,878,000
-19.4%
58,958
-0.1%
0.02%
-36.7%
Q4 2020$7,297,000
+36.6%
58,993
+7.6%
0.03%
+15.4%
Q3 2020$5,341,00054,8380.03%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders